ホミノベン(18053-31-1)

ChemicalBook Optimization Suppliers
名前: LGM Pharma  
電話番号: 1-(800)-881-8210
電子メール: inquiries@lgmpharma.com
名前: Guangzhou Isun Pharmaceutical Co., Ltd  
電話番号: 020-39119399 18927568969
電子メール: isunpharm@qq.com
名前: Amadis Chemical Company Limited  
電話番号: 571-89925085
電子メール: sales@amadischem.com
名前: Dideu Industries Group Limited  
電話番号: +86-29-89586680 +86-15129568250
電子メール: 1026@dideu.com
名前: Career Henan Chemica Co  
電話番号: +86-0371-86658258 15093356674;
電子メール: laboratory@coreychem.com
ホミノベン 製品概要
化学名:ホミノベン
英語化学名:Fominoben
别名:FOMINOBEN;3'-Chloro-2'-(N-methyl-N-((morpholinocarbonyl)methyl)aminomethyl)benzanilide;N-[3-Chloro-2-[[methyl-(2-morpholin-4-yl-2-oxoethyl)amino]methyl]phenyl]benzamide;3'-Chloro-a-[methyl[(morpholinocarbonyl)methyl]amino]-o-benzotoluidide;Benzamide, N-[3-chloro-2-[[methyl[2-(4-morpholinyl)-2-oxoethyl]amino]methyl]phenyl]-;N-(2-Benzoylamino-6-chlorobenzyl)-N-methylglycine morpholide;Terion;Fominoben USP/EP/BP
CAS番号:18053-31-1
分子式:C21H24ClN3O3
分子量:401.89
EINECS:241-964-4
カテゴリ情報:
Mol File:18053-31-1.mol
ホミノベン
ホミノベン 物理性質
融点 122.5-123°
CAS データベース18053-31-1(CAS DataBase Reference)
安全性情報
MSDS Information
ProviderLanguage
Fominoben English
ホミノベン Usage And Synthesis
効能鎮咳薬
OriginatorNoleptan,Thomae,W. Germany,1973
定義ChEBI: Fominoben is a member of benzamides.
Manufacturing Process(a) A mixture consisting of 9.75 g of 6-chloro-2-dibenzoylamino-benzyl bromide, 2.34 g of sarcosine methyl ester, 3.18 ml of triethylamine and 250 ml of chloroform was refluxed for five hours. Thereafter, an addition 0.5 g of sarcosine methyl ester was added, and the mixture was again refluxed for five hours. Subsequently, the chloroform was evaporated in vacuo, the residue was taken up in ethylacetate, the insoluble matter was separated by filtration, and the filtrate was again evaporated in vacuo. The residual oil was dissolved in methanol, the solution was admixed with 25 ml of 2 N sodium hydroxide, and the mixture was allowed to stand overnight at about 20°C. Thereafter, the methanol was evaporated in vacuo, and the residual aqueous solution was adjusted to pH 2 with 2 N hydrochloric acid, then extracted with ethyl acetate and then adjusted to pH 6 with 2N sodium hydroxide. The crystalline product precipitated thereby was collected by vacuum filtration and recrystallized from water, yielding N-(2-benzoylamino-6-chloro-benzyl)-N-methyl-glycine, MP 150°C to 152°C.
(b) 80.7 g of N-(2-benzoylamino-6-chlorobenzyl)-N-methyl-glycine and 38 ml of triethylamine were dissolved in 1 liter of dry chloroform. While stirring the resulting solution at -15°C to -5°C, 23.4 ml of ethyl chloroformate were rapidly added dropwise, and the mixture was stirred for 40 minutes more at - 15°C to -5°C. Thereafter, 50 ml of morpholine were added all at once, and the mixture was allowed to stand at 20°C for 20 hours. Subsequently, the chloroformic reaction solution was washed three times with brine, dried over magnesium sulfate and evaporated in vacuo, and the oily residue was taken up in ether, whereupon it crystallized. The crystalline product was recrystallized from methanol, yielding N-(2-benzoyl-amino-6-chloro-benzyl)-Nmethyl-glycine-morpholide, MP 122.5°C to 123°C.
The product was dissolved in isopropanol, and the solution was acidified with anhydrous hydrochloric acid, yielding the hydrochloride, MP 206°C to 208°C (decomp.).
Therapeutic FunctionAntitussive, Respiratory stimulant Fominoben hydrochloride
Tags:18053-31-1